XOMA Royalty Corp. (XOMA)
41.67
-0.15
(-0.36%)
USD |
NASDAQ |
May 22, 16:00
41.67
0.00 (0.00%)
After-Hours: 16:45
XOMA Royalty EPS Diluted (Quarterly) : 0.173 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | -0.6712 |
| Galera Therapeutics, Inc. | -0.0163 |
| Organon & Co. | 0.5554 |
| Rezolute, Inc. | -0.1554 |
| Outlook Therapeutics, Inc. | -0.0544 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.573M |
| Revenue (Quarterly) | 12.32M |
| Total Expenses (Quarterly) | 8.745M |
| Enterprise Value | 574.31M |
| Gross Profit Margin (Quarterly) | 92.73% |
| Profit Margin (Quarterly) | 29.01% |
| Earnings Yield | 3.77% |
| Operating Earnings Yield | 0.67% |
| Normalized Earnings Yield | 3.633 |